Pages with the fewest revisions

Jump to: navigation, search

Showing below up to 418 results in range #1 to #418.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Surveillance attributes for evaluation‏‎ (1 revision - redirect page)
  2. Testing the Tests‏‎ (1 revision - redirect page)
  3. Surveillance of HAIs in intensive care units‏‎ (1 revision)
  4. Case Definitions‏‎ (1 revision - redirect page)
  5. Construction of Epidemic Curves‏‎ (1 revision - redirect page)
  6. Possible Terrorist / Deliberate Event‏‎ (1 revision)
  7. Public Health Microbiology‏‎ (1 revision - redirect page)
  8. Host‏‎ (1 revision - redirect page)
  9. Decision 1082/2013/EU: Serious cross border health threat‏‎ (1 revision - redirect page)
  10. Expert Advice‏‎ (1 revision)
  11. Statistical Tests‏‎ (1 revision - redirect page)
  12. Establishing a Surveillance System‏‎ (1 revision - redirect page)
  13. Hand hygiene products selection and evaluation‏‎ (1 revision - redirect page)
  14. Types of Study‏‎ (1 revision - redirect page)
  15. The European Surveillance System (TESSy)‏‎ (1 revision)
  16. Fitting logistic regression models‏‎ (1 revision - redirect page)
  17. Graphs, charts, diagrams‏‎ (1 revision - redirect page)
  18. Health communication‏‎ (1 revision - redirect page)
  19. Public Health Programs‏‎ (1 revision - redirect page)
  20. Main Page‏‎ (1 revision - redirect page)
  21. Significance and Confidence‏‎ (1 revision - redirect page)
  22. Types of HAIs‏‎ (1 revision - redirect page)
  23. Effect Modification and Confounding‏‎ (1 revision - redirect page)
  24. Eye, Ear, Nose or Mouth Infection‏‎ (1 revision)
  25. ECDC PPS in acute care hospitals‏‎ (1 revision - redirect page)
  26. Root‏‎ (1 revision - redirect page)
  27. Lobbying‏‎ (1 revision)
  28. Public Health Informatics‏‎ (1 revision - redirect page)
  29. International Health Regulations 2005 edition‏‎ (1 revision - redirect page)
  30. Statistical Concepts‏‎ (1 revision - redirect page)
  31. Privacy policy‏‎ (1 revision)
  32. Analysis of Surveillance Data‏‎ (1 revision - redirect page)
  33. Information (Measurement) Bias‏‎ (1 revision - redirect page)
  34. Gastrointestinal System Infections‏‎ (1 revision)
  35. Matching‏‎ (1 revision - redirect page)
  36. Rationale for Outbreak Investigations‏‎ (1 revision - redirect page)
  37. Presenting Statistics‏‎ (1 revision)
  38. About‏‎ (1 revision)
  39. Evaluation of Surveillance Systems‏‎ (1 revision - redirect page)
  40. Lower Respiratory Tract Infection other than pneumonia‏‎ (1 revision)
  41. Confirm the outbreak‏‎ (1 revision - redirect page)
  42. Opportunities and Challenges‏‎ (1 revision - redirect page)
  43. Informing Action / Improving Knowledge‏‎ (1 revision - redirect page)
  44. Prevention‏‎ (1 revision - redirect page)
  45. Models‏‎ (1 revision - redirect page)
  46. Field Epidemiology‏‎ (1 revision - redirect page)
  47. Types of Outbreak‏‎ (1 revision - redirect page)
  48. Rash diseases in childhood‏‎ (1 revision - redirect page)
  49. Health Economics‏‎ (1 revision - redirect page)
  50. Logistic Regression‏‎ (1 revision - redirect page)
  51. Assessing the burden of disease and risk assessment‏‎ (1 revision - redirect page)
  52. Infection control and hospital hygiene‏‎ (1 revision - redirect page)
  53. Case-control studies‏‎ (1 revision - redirect page)
  54. Reproductive Tract Infections‏‎ (1 revision)
  55. Hints to Design a Good Questionnaire‏‎ (1 revision - redirect page)
  56. Data Capture Systems‏‎ (1 revision - redirect page)
  57. Applied Immunology‏‎ (1 revision - redirect page)
  58. Descriptive data analysis‏‎ (1 revision - redirect page)
  59. Measurement in Field Epidemiology‏‎ (1 revision - redirect page)
  60. Infection control interventions‏‎ (1 revision - redirect page)
  61. The role of the clinical microbiology laboratory in infection prevention and control‏‎ (1 revision - redirect page)
  62. Skin and Soft Tissue Infections‏‎ (1 revision)
  63. HAI Surveillance at the EU level - importance of international networks‏‎ (1 revision - redirect page)
  64. Communication of findings‏‎ (1 revision - redirect page)
  65. Analysis by place characteristics‏‎ (1 revision - redirect page)
  66. Healthcare-associated infection prevention and control as a part of patient safety programme‏‎ (1 revision - redirect page)
  67. Cluster Investigations‏‎ (1 revision - redirect page)
  68. Selection Bias‏‎ (1 revision - redirect page)
  69. Specific Neonatal Case definitions‏‎ (1 revision)
  70. Non-traditional designs‏‎ (1 revision - redirect page)
  71. Rubella‏‎ (1 revision)
  72. Spatial Analysis (Geographical Information Systems)‏‎ (1 revision)
  73. Healthcare-associated infection prevention and control programme‏‎ (1 revision - redirect page)
  74. Selection bias and case-control studies‏‎ (1 revision - redirect page)
  75. Surgical Site Infection‏‎ (1 revision)
  76. Presenting Data‏‎ (1 revision)
  77. Writing a Study Protocol‏‎ (1 revision - redirect page)
  78. Types of Questions‏‎ (1 revision - redirect page)
  79. Vaccination‏‎ (1 revision - redirect page)
  80. Analysis by time characteristics‏‎ (1 revision - redirect page)
  81. Types of Cluster‏‎ (1 revision)
  82. Methods in Field Epidemiology‏‎ (1 revision - redirect page)
  83. Surveillance and investigation of healthcare-associated infections‏‎ (1 revision - redirect page)
  84. Systemic Infections‏‎ (1 revision)
  85. To professionals‏‎ (1 revision - redirect page)
  86. Health Informatics Standards – general introduction‏‎ (1 revision - redirect page)
  87. Epidemic intelligence‏‎ (1 revision - redirect page)
  88. Measures of Disease Impact‏‎ (1 revision - redirect page)
  89. Case definitions of healthcare infections‏‎ (1 revision - redirect page)
  90. Choosing a Reference Group‏‎ (1 revision - redirect page)
  91. Urinary Tract Infection‏‎ (1 revision)
  92. Outbreak Investigations‏‎ (1 revision - redirect page)
  93. Screening‏‎ (1 revision - redirect page)
  94. Writing for Publications‏‎ (1 revision - redirect page)
  95. Power and Sample Size‏‎ (1 revision - redirect page)
  96. Rapid Risk Assessment‏‎ (1 revision - redirect page)
  97. Healthcare-associated infections and risk assessment‏‎ (1 revision - redirect page)
  98. Measures of Disease Occurrence‏‎ (1 revision - redirect page)
  99. Hand hygiene‏‎ (1 revision - redirect page)
  100. Hand hygiene - principles‏‎ (1 revision - redirect page)
  101. European surveillance of healthcare-associated infections‏‎ (1 revision - redirect page)
  102. Surveillance of healthcare-associated infections - definition‏‎ (1 revision - redirect page)
  103. How pathogens try to trick our defenses‏‎ (1 revision - redirect page)
  104. Stratified Analysis‏‎ (1 revision - redirect page)
  105. Surveillance principles‏‎ (1 revision - redirect page)
  106. Burden of HAIs‏‎ (1 revision)
  107. Odds‏‎ (1 revision - redirect page)
  108. Scientific (evidence base for prevention)‏‎ (1 revision - redirect page)
  109. HAI case definitions for use in hospitals‏‎ (1 revision - redirect page)
  110. ECDC point prevalence survey of healthcare-associated infections and antimicrobial use in long term care facilities‏‎ (1 revision)
  111. Refining the estimated point in time of an outbreak source‏‎ (1 revision - redirect page)
  112. Investigations in Special Circumstances‏‎ (1 revision - redirect page)
  113. Analysing a public health problem‏‎ (1 revision - redirect page)
  114. Public Health Interventions‏‎ (1 revision - redirect page)
  115. EU Public Health Legislation‏‎ (1 revision - redirect page)
  116. Main pathogens and resistance‏‎ (1 revision - redirect page)
  117. Problems with Measurement‏‎ (1 revision - redirect page)
  118. Causal Inference‏‎ (1 revision - redirect page)
  119. Bone and Joint Infection‏‎ (1 revision)
  120. ECDC surveillance of Surgical Site Infections‏‎ (1 revision)
  121. Surveillance of healthcare-associated infections - other approaches‏‎ (1 revision - redirect page)
  122. Introduction to Public Health and basic concepts‏‎ (1 revision - redirect page)
  123. The Role of Microbiology‏‎ (1 revision - redirect page)
  124. Sampling‏‎ (1 revision - redirect page)
  125. Indicator-based Surveillance‏‎ (1 revision - redirect page)
  126. Bias‏‎ (1 revision - redirect page)
  127. Cohort studies‏‎ (1 revision - redirect page)
  128. Surveillance of Clostridium difficile infections‏‎ (1 revision)
  129. Case definitions for outbreak assessment‏‎ (1 revision - redirect page)
  130. Describe the outbreak‏‎ (1 revision - redirect page)
  131. Health care settings‏‎ (1 revision)
  132. General Communication‏‎ (1 revision - redirect page)
  133. Questionnaire Design‏‎ (1 revision - redirect page)
  134. Public Health Law‏‎ (1 revision - redirect page)
  135. Bioinformatics‏‎ (1 revision)
  136. Microbial flora of the hands‏‎ (2 revisions)
  137. Indications for hand hygiene‏‎ (2 revisions)
  138. Standardization of rates‏‎ (2 revisions)
  139. Measures of association‏‎ (2 revisions)
  140. Capture-recapture‏‎ (2 revisions)
  141. Nails, rings, watches, bracelets‏‎ (2 revisions)
  142. Central Nervous System Infection‏‎ (2 revisions)
  143. Laboratory Support‏‎ (2 revisions)
  144. Types of Surveillance System (Active vs Passive)‏‎ (2 revisions)
  145. Skin care‏‎ (2 revisions)
  146. Glossary‏‎ (2 revisions)
  147. Aesthetic preferences‏‎ (2 revisions)
  148. Analytical Study Designs‏‎ (2 revisions)
  149. Source of infection‏‎ (2 revisions)
  150. Evaluation of the microbicidal activities of hand-rub and hand-wash agents‏‎ (2 revisions)
  151. ECDC PPS in European acute care hospitals protocol‏‎ (2 revisions)
  152. Frequency polygons‏‎ (2 revisions)
  153. Health advocacy‏‎ (2 revisions)
  154. Transmission routes‏‎ (2 revisions)
  155. Applying Epidemiology for the International Health Regulations.‏‎ (2 revisions)
  156. Interviewer Bias‏‎ (2 revisions)
  157. Pilot testing‏‎ (2 revisions)
  158. Cross-sectional Studies‏‎ (2 revisions)
  159. ECDC PPS in European acute care hospitals, definition of HAI‏‎ (2 revisions)
  160. Public health response (informing control)‏‎ (2 revisions)
  161. The idea of Statistical Inference‏‎ (2 revisions)
  162. Recall Bias‏‎ (2 revisions)
  163. Product accessibility and cost‏‎ (2 revisions)
  164. Measures of effect in various study designs‏‎ (2 revisions)
  165. Additional resources for presenting findings‏‎ (2 revisions)
  166. Line graphs‏‎ (2 revisions)
  167. Health literacy‏‎ (2 revisions)
  168. Validated questionnaires‏‎ (2 revisions)
  169. Hygiene and Sanitation‏‎ (2 revisions)
  170. Incidence rate‏‎ (2 revisions)
  171. Types of Microorganisms‏‎ (2 revisions)
  172. Reporting Bias‏‎ (2 revisions)
  173. Methods for assessing environmental cleanliness‏‎ (2 revisions)
  174. Restriction‏‎ (2 revisions)
  175. ECDC PPS - inclusion/exclusion criteria‏‎ (2 revisions)
  176. Cost-effectiveness‏‎ (2 revisions)
  177. Outbreak communication‏‎ (2 revisions)
  178. Antimicrobial stewardship‏‎ (2 revisions)
  179. Response Bias‏‎ (2 revisions)
  180. Test Reproducibility‏‎ (2 revisions)
  181. Cost-minimisation‏‎ (2 revisions)
  182. Probability‏‎ (2 revisions)
  183. Cohorting patients and/or staff‏‎ (2 revisions)
  184. Molecular epidemiology‏‎ (2 revisions)
  185. To Public and the Media‏‎ (2 revisions)
  186. Cost-utility‏‎ (2 revisions)
  187. Social marketing‏‎ (2 revisions)
  188. Tertiary prevention‏‎ (2 revisions)
  189. Antigen presenting cells (APC)‏‎ (2 revisions)
  190. European Antimicrobial Resistance Surveillance Network (EARS-Net)‏‎ (2 revisions)
  191. Scarlatina‏‎ (2 revisions)
  192. Interpreting Data‏‎ (2 revisions)
  193. Web-crawling Applications‏‎ (2 revisions)
  194. Antigens (Ag)‏‎ (2 revisions)
  195. Cooperative learning as active learning in adult‏‎ (2 revisions)
  196. Developing infection control interventions: isolation‏‎ (2 revisions)
  197. Case to case study design‏‎ (2 revisions)
  198. European Surveillance of Antimicrobial Consumption Network (ESAC-Net)‏‎ (2 revisions)
  199. Roseola‏‎ (2 revisions)
  200. Tables‏‎ (2 revisions)
  201. Sensitivity Analysis‏‎ (2 revisions)
  202. Herd immunity‏‎ (2 revisions)
  203. Mechanism of infectious disease‏‎ (2 revisions)
  204. Education and training of staff‏‎ (2 revisions)
  205. Descriptive Studies‏‎ (2 revisions)
  206. Unmasking Outbreak Source through Segmentation‏‎ (2 revisions)
  207. HFMD‏‎ (2 revisions)
  208. Measuring protection‏‎ (2 revisions)
  209. What determines our susceptibility to infections?‏‎ (2 revisions)
  210. Non-response bias‏‎ (2 revisions)
  211. Experimental Studies‏‎ (2 revisions)
  212. Use of computers‏‎ (2 revisions)
  213. Writing for Stakeholders‏‎ (2 revisions)
  214. Gloves and hand hygiene‏‎ (2 revisions)
  215. Developing a control definition‏‎ (2 revisions)
  216. Structure of an Outbreak Investigation Report‏‎ (2 revisions)
  217. Measures of Accuracy in Screening‏‎ (2 revisions)
  218. Sources and Types of Surveillance Data‏‎ (2 revisions)
  219. Helminthic mechanisms of immune evasion‏‎ (2 revisions)
  220. Dose Effect‏‎ (2 revisions)
  221. Survival bias‏‎ (2 revisions)
  222. The outbreak management team‏‎ (2 revisions)
  223. Incubation period, Latent period and Generation time‏‎ (2 revisions)
  224. Cognitive bias‏‎ (2 revisions)
  225. Disasters and Emergencies‏‎ (2 revisions)
  226. SMART definitions‏‎ (2 revisions)
  227. EU Food Safety Legislation‏‎ (2 revisions)
  228. Sources and Types of Data‏‎ (2 revisions)
  229. Detection Bias‏‎ (2 revisions)
  230. Hand hygiene methods‏‎ (2 revisions)
  231. Hand hygiene for patients and visitors‏‎ (2 revisions)
  232. Cardiovascular System Infection‏‎ (2 revisions)
  233. Political Interests and Populism‏‎ (2 revisions)
  234. EU Legislation for Communicable Diseases Surveillance‏‎ (2 revisions)
  235. Misinformation and False Evidence‏‎ (3 revisions)
  236. SOCO (single over-riding communications objective)‏‎ (3 revisions)
  237. Advantages and Disadvantages of Questionnaires‏‎ (3 revisions)
  238. Residual Confounding‏‎ (3 revisions)
  239. Multidrug-resistant organisms (MDRO)‏‎ (3 revisions)
  240. Measuring risk‏‎ (3 revisions)
  241. Defining a Case‏‎ (3 revisions)
  242. Diagnostic Applications of the Epidemic Curve‏‎ (3 revisions)
  243. Reservoir for infectious agents‏‎ (3 revisions)
  244. Quality checking‏‎ (3 revisions)
  245. Some key recitals under 1082‏‎ (3 revisions)
  246. Reference group for cohort studies‏‎ (3 revisions)
  247. Sensitivity and Specificity of a case definition‏‎ (3 revisions)
  248. Disentangling Complex Data‏‎ (3 revisions)
  249. Schools‏‎ (3 revisions)
  250. Crisis communication‏‎ (3 revisions)
  251. Confidence Intervals‏‎ (3 revisions)
  252. CAUTI‏‎ (3 revisions)
  253. Parallel versus Serial testing‏‎ (3 revisions)
  254. Apps for epidemiologists‏‎ (3 revisions)
  255. Risks and rates‏‎ (3 revisions)
  256. Significant probability to be different from the expected‏‎ (3 revisions)
  257. CLABSI‏‎ (3 revisions)
  258. Advantages and disadvantages of matching‏‎ (3 revisions)
  259. Types of Questionnaires‏‎ (3 revisions)
  260. Software for epidemiologists‏‎ (3 revisions)
  261. SSI‏‎ (3 revisions)
  262. Isolation of patients with Clostridium difficile infection (CDI)‏‎ (3 revisions)
  263. Test Precision‏‎ (3 revisions)
  264. Pneumonia‏‎ (3 revisions)
  265. Principles of matching‏‎ (3 revisions)
  266. ECDC PPS - antimicrobial use definition‏‎ (3 revisions)
  267. Combining Studies: Meta-Analysis‏‎ (3 revisions)
  268. VAP‏‎ (3 revisions)
  269. Test reliability‏‎ (3 revisions)
  270. Stage 0: Preparation for rapid risk assessment‏‎ (3 revisions)
  271. Risk communication‏‎ (3 revisions)
  272. Questionnaire Layout and Coding‏‎ (3 revisions)
  273. Secondary prevention‏‎ (3 revisions)
  274. Stage 1: Collecting event information‏‎ (3 revisions)
  275. Antibodies‏‎ (3 revisions)
  276. Threshold setting‏‎ (3 revisions)
  277. ECDC Programme on antimicrobial resistance and healthcare-associated infections‏‎ (3 revisions)
  278. Identifying Multiple Possible Outbreak Sources‏‎ (3 revisions)
  279. Maps‏‎ (3 revisions)
  280. Seven Golden Rules to Design Questions‏‎ (3 revisions)
  281. Online Reporting‏‎ (3 revisions)
  282. Stage 2: Systematically collecting information‏‎ (3 revisions)
  283. Statistical Methods for Cluster Investigation‏‎ (3 revisions)
  284. Contact precautions‏‎ (3 revisions)
  285. Stage 3: Extracting relevant evidence‏‎ (3 revisions)
  286. Relation between risk and incidence rate‏‎ (3 revisions)
  287. Model building strategies‏‎ (3 revisions)
  288. Ascertainment Bias‏‎ (3 revisions)
  289. Environment as a source of healthcare-associated infections‏‎ (3 revisions)
  290. Health Informatics Standards - Health Information Systems and Processes‏‎ (3 revisions)
  291. Bloodstream Infection‏‎ (3 revisions)
  292. Vector Borne‏‎ (3 revisions)
  293. Varicella‏‎ (3 revisions)
  294. Frequent Problems with writing an Outbreak Investigation Report‏‎ (3 revisions)
  295. Checklist for posters‏‎ (3 revisions)
  296. Health Informatics Standards - Standard Content‏‎ (3 revisions)
  297. Criteria for Surveillance‏‎ (3 revisions)
  298. Brief history of International Communicable Disease Law‏‎ (3 revisions)
  299. Criteria for confounding‏‎ (3 revisions)
  300. Referral bias‏‎ (3 revisions)
  301. Five moments for hand hygiene‏‎ (3 revisions)
  302. Outbreak steps : additional points‏‎ (3 revisions)
  303. Scientific paper review form‏‎ (3 revisions)
  304. The Mantel Haenszel Method‏‎ (3 revisions)
  305. Event-based Surveillance‏‎ (3 revisions)
  306. Hand hygiene education and promotion‏‎ (3 revisions)
  307. Hand hygiene before invasive procedures‏‎ (3 revisions)
  308. Selection bias and cohort studies‏‎ (3 revisions)
  309. Surveillance for MV Patients in the ICU‏‎ (3 revisions)
  310. Writing style of an Outbreak Investigation Report‏‎ (3 revisions)
  311. Host tracing‏‎ (3 revisions)
  312. Quality, Governance, and Operating Procedures‏‎ (3 revisions)
  313. Catheter-Related Infection‏‎ (4 revisions)
  314. Measuring incidence rates‏‎ (4 revisions)
  315. Diagnostic tests versus screening test‏‎ (4 revisions)
  316. Bar graphs‏‎ (4 revisions)
  317. Surveillance - Opportunities and Challenges‏‎ (4 revisions)
  318. Advantages and disadvantages of cohort and case control studies‏‎ (4 revisions)
  319. Semmelweis‏‎ (4 revisions)
  320. Use of Epidemic Curves for characterising Outbreak Sources‏‎ (4 revisions)
  321. Immunization of health care workers‏‎ (4 revisions)
  322. Histograms‏‎ (4 revisions)
  323. Health education‏‎ (4 revisions)
  324. Attack rate‏‎ (4 revisions)
  325. Practical Aspects of Specimen Collection and Shipment‏‎ (4 revisions)
  326. Selection and evaluation for specific products‏‎ (4 revisions)
  327. Erythema infectiosa‏‎ (4 revisions)
  328. Other types of data display‏‎ (4 revisions)
  329. Primary prevention‏‎ (4 revisions)
  330. Microbial typing‏‎ (4 revisions)
  331. Table format and Analysis‏‎ (4 revisions)
  332. Distinguishing Different Sources or Modes of Transmission during an outbreak‏‎ (4 revisions)
  333. Pre-emptive isolation‏‎ (4 revisions)
  334. Validity and accuracy‏‎ (4 revisions)
  335. Person to Person‏‎ (4 revisions)
  336. Format of closed questions‏‎ (4 revisions)
  337. Diagnostic bias‏‎ (4 revisions)
  338. Standard precautions‏‎ (4 revisions)
  339. Definition of an Outbreak Investigation Report‏‎ (4 revisions)
  340. Surveillance or Research‏‎ (4 revisions)
  341. Confounding in studies‏‎ (4 revisions)
  342. Control Selection‏‎ (4 revisions)
  343. Evaluation of Screening‏‎ (4 revisions)
  344. Formal Risk Assessment‏‎ (4 revisions)
  345. Common errors in surveillance data analysis‏‎ (4 revisions)
  346. Special Considerations in Control Selection‏‎ (4 revisions)
  347. Writing an Outbreak Investigation Report‏‎ (4 revisions)
  348. Principles of Screening‏‎ (4 revisions)
  349. Contact tracing‏‎ (4 revisions)
  350. Surveillance System Design and Operation‏‎ (4 revisions)
  351. Effect Modification‏‎ (4 revisions)
  352. Antimicrobial resistance‏‎ (4 revisions)
  353. Causal mechanisms‏‎ (4 revisions)
  354. Concepts in sampling‏‎ (4 revisions)
  355. Uses of Surveillance Data‏‎ (4 revisions)
  356. Acquired resistance‏‎ (4 revisions)
  357. Mechanisms of antimicrobial resistance‏‎ (5 revisions)
  358. Viewpoints for Causality (Bradford Hill)‏‎ (5 revisions)
  359. Scientific Uncertainty‏‎ (5 revisions)
  360. Impact numbers‏‎ (5 revisions)
  361. Piloting Questionnaires‏‎ (5 revisions)
  362. Various Levels of Case Definition‏‎ (5 revisions)
  363. Measures of disease impact - Further reading‏‎ (5 revisions)
  364. Receiver operating curve‏‎ (5 revisions)
  365. Continuing Source‏‎ (5 revisions)
  366. Quantifying disease burden‏‎ (5 revisions)
  367. Case-cohort study‏‎ (5 revisions)
  368. Methods for setting thresholds in time series analysis‏‎ (5 revisions)
  369. The Role of Surveillance‏‎ (5 revisions)
  370. Prevalence‏‎ (5 revisions)
  371. The Components of Surveillance‏‎ (5 revisions)
  372. Reprocessing of flexible endoscopes‏‎ (5 revisions)
  373. Checklist for study protocols‏‎ (5 revisions)
  374. Objectives of Surveillance‏‎ (5 revisions)
  375. Healthcare-Associated Infections Network (HAI-Net)‏‎ (5 revisions)
  376. Types of variables and line listing‏‎ (5 revisions)
  377. Key definitions in infectious diseases epidemiology‏‎ (5 revisions)
  378. Prisons‏‎ (6 revisions)
  379. Bias in Questionnaires‏‎ (6 revisions)
  380. Analysis by person characteristics‏‎ (6 revisions)
  381. Hospital cleaning and decontamination‏‎ (6 revisions)
  382. Estimating Odds Ratios in the presence of interaction‏‎ (6 revisions)
  383. Measles‏‎ (6 revisions)
  384. Pie charts‏‎ (6 revisions)
  385. Density case control studies‏‎ (6 revisions)
  386. Case cross over studies‏‎ (6 revisions)
  387. Measuring the Quality of Healthcare‏‎ (6 revisions)
  388. Point Source‏‎ (6 revisions)
  389. Risks and Rates‏‎ (6 revisions)
  390. Data collection instrument‏‎ (6 revisions)
  391. Outbreak investigations: 10 steps, 10 pitfalls‏‎ (6 revisions)
  392. Interaction‏‎ (6 revisions)
  393. 10 common errors in surveillance evaluations‏‎ (7 revisions)
  394. Which indicator to map?‏‎ (7 revisions)
  395. Measures of impact among the exposed‏‎ (7 revisions)
  396. Weblinks for epidemiologists‏‎ (7 revisions)
  397. FEM Users code of conduct‏‎ (7 revisions)
  398. Traditional case-control studies‏‎ (7 revisions)
  399. Surveillance methodologies for healthcare associated infections‏‎ (7 revisions)
  400. Policy and Real World Evidence‏‎ (7 revisions)
  401. Ten Steps to Design a Questionnaire‏‎ (8 revisions)
  402. Smoothing techniques‏‎ (8 revisions)
  403. Analysis, Interpretation, and Dissemination‏‎ (9 revisions)
  404. Preventing bias‏‎ (9 revisions)
  405. Linear models‏‎ (9 revisions)
  406. Epidemiological/public health role of the clinical microbiology laboratory‏‎ (9 revisions)
  407. Aide memoire for oral presentations and visual aids‏‎ (10 revisions)
  408. Choosing an appropriate type of map‏‎ (10 revisions)
  409. Choosing a method of data display‏‎ (10 revisions)
  410. Clinical role of the microbiology laboratory‏‎ (10 revisions)
  411. Table measuring risk, rate and odds ratio‏‎ (10 revisions)
  412. The logistic model‏‎ (10 revisions)
  413. Stage 5; Estimating the risk‏‎ (10 revisions)
  414. Measures of impact in the population‏‎ (11 revisions)
  415. Electronic Data Transfer‏‎ (11 revisions)
  416. Interpreting model coefficients‏‎ (11 revisions)
  417. Stage 4: Appraising evidence‏‎ (15 revisions)
  418. FEM-WIKI‏‎ (71 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)